dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· October 3, 2026

Aetna 2027 Medicare plans offer reliable, affordable access to care & member support

View original at finance.yahoo.com
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support Plans designed to provide member value and access to care: $0 copays on Tier 1 drugs and covered vaccines at in-network pharmacies* $0 copays for annual physicals, colonoscopies and mammograms at in-network providers $0 copays for annu…
Opening lines of the source · Yahoo Finance · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • In every county where Aetna Medicare Advantage plans are available, at least one plan has a $0 monthly premium with low or no primary care copays, and at least one plan has an over-the-counter allowance.

    60% confidence

  • Aetna's 2027 plans put members and their experience at the center, offering benefits and services they can trust to support their health needs.

    60% confidence

  • Aetna offers $0 copays for annual physicals, colonoscopies, mammograms, and routine eye and hearing exams at in-network providers; most plans have $0 primary care copays and many have $0 copays for labs.

    60% confidence

  • Aetna is giving renewed focus to HMO products because of the value they offer members, expanding Prime HMO offerings in select markets at lower cost.

    60% confidence

  • All 2027 Aetna Medicare Advantage plans have $0 copays for Tier 1 drugs at preferred pharmacies and include dental, vision and hearing benefits plus a SilverSneakers basic fitness membership.

    60% confidence

Cité dans ces articles de Via News

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support: Source | Via News | fr.via.news